Recovery
Recovery peptides
Tissue-repair and recovery compounds such as BPC-157, TB-500, and GHK-Cu, chosen to support healing, connective tissue, and resilience. Each profile covers mechanism, dosing ranges, and the evidence behind it.
Compounds in this category
How recovery peptides work
Recovery peptides target the repair side of training and injury. BPC-157, a synthetic fragment of a gastric protective protein, is studied for its effects on angiogenesis (new blood-vessel growth) and tendon, ligament, and gut-lining repair. TB-500 (thymosin beta-4) influences actin regulation and cell migration to support muscle and connective-tissue healing, while GHK-Cu, a copper-binding peptide, drives collagen synthesis and skin remodeling.
In practice these are run in short cycles around an injury or a high-volume training block, and are often combined — BPC-157 + TB-500 is a common pairing — so the angiogenic and structural-repair mechanisms complement each other.
Research context
Be clear-eyed about the evidence: most recovery-peptide data is preclinical — animal models and in-vitro work — with limited controlled human trials. The mechanistic rationale is strong and anecdotal human use is widespread, but large randomized human outcome trials are still lacking for BPC-157 and TB-500.
GHK-Cu has the most direct human support, largely from dermatology and wound-healing research on collagen and skin quality. Treat the others as promising, mechanism-led options rather than settled clinical therapies.
Safety considerations
These remain research compounds. Reported tolerability is generally good at studied doses, but the lack of long-term human safety data means clinician oversight and conservative, cycled dosing are sensible. GHK-Cu is avoided in Wilson's disease (copper handling), and any compound that promotes angiogenesis warrants caution with an active malignancy.
Source matters: use only third-party-tested material from a reputable supplier, with correct reconstitution and sterile technique. None of this is a substitute for appropriate medical care for a serious injury.
Educational information only — not medical advice, a diagnosis, or a prescription. Peptides discussed here should be used under the supervision of a licensed clinician.
Related compounds & protocols
Frequently asked questions
BPC-157 or TB-500 — which should I use?
They work through different mechanisms and are often used together. BPC-157 leans toward tendon, ligament, and gut repair; TB-500 toward muscle and broader connective-tissue recovery. The right choice depends on the injury and the goal.
How long is a typical cycle?
Recovery protocols are usually short — on the order of 4–8 weeks around an injury or training block — rather than continuous, with a break afterward.
Is the evidence solid?
The mechanisms are well-described and human use is common, but most controlled data is animal or in-vitro. GHK-Cu has the strongest direct human evidence. We flag evidence quality on each compound so you can weigh it honestly.